Trial Results Search
Clinical Trial Results: Hepatitis B, Chronic
-
Protocol Number: ML18089
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 03.11.2008
Phase: III
-
Protocol Number: ML25647
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: MV22430
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML18286
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 01.02.2011
Phase: III
-
Protocol Number: ML17619
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 02.02.2007
Phase: III
-
Protocol Number: ML18376
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 01.06.2010
Phase: IV
-
Protocol Number: BV28333
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
A Retrospective Biomarker Study of Stored Samples Obtained from Patients With Chronic Hepatitis B
-
Protocol Number: ML28470
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: III
-
Protocol Number: MV22597
Product Name: PEGINTERFERON ALFA-2A
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML22265
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML21827
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: WV19432
Product Name: peginterferon alfa-2a
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML18253
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: III
-
Protocol Number: ML20601
Product Name: peginterferon alfa-2a
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML20135
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML20742
Product Name: peginterferon alfa-2a
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML28262
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: II
-
Protocol Number: YV25718
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: III
-
Protocol Number: PP22612
Product Name: PEGASYS [peginterferon alfa-2a (40KB)]
Date of Report: To be Published
Phase: I
-
Protocol Number: ML22266
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: GV28855
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML20622
Product Name: peginterferon alfa-2a
Date of Report: To be Published
Phase: III
-
Protocol Number: MV22009
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
-
Protocol Number: ML28516
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML28346
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25626
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML22016
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25614
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML18495
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 31.10.2008
Phase: IV
-
Protocol Number: ML20003
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 01.12.2010
Phase: IV
-
Protocol Number: ML18092
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 17.12.2007
Phase: IV
-
Protocol Number: PP22512
Product Name: peginterferon alfa-2a [Pegasys] [peginterferon alfa-2a]
Date of Report: 01.09.2012
Phase: I
-
Protocol Number: ML18675
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: III
-
Protocol Number: ML17700
Product Name: PEGASYS [peginterferon alfa-2a (40KD)]
Date of Report: 03.04.2006
Phase: IV
-
Protocol Number: ML19295
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 30.07.2010
Phase: IV
-
Protocol Number: ML19522
Product Name: Pegasys [peginterferon alfa-2a [Pegasys]]
Date of Report: 01.12.2012
Phase: IV
-
Protocol Number: ML20020
Product Name: Pegasys [peginterferon alfa-2a]
Date of Report: To be Published
Phase: II
About This Database
This database is populated with information on the results of Roche-sponsored clinical trials.